Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials-Reference-Cited by-同舟云学术

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials

Published:2019-12 Issue:12 Volume:19 Page:e444-e451
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Lanini Simone,Ioannidis John P A,Vairo Francesco,Pletschette Michel,Portella Gina,Di Bari Virginia,Mammone Alessia,Pisapia Raffaella,Merler Stefano,Nguhuni Boniface,Langer Martin,Di Caro Antonino,Edwards Sarah J L,Petrosillo Nicola,Zumla Alimuddin,Ippolito Giuseppe

Funder

PANDORA-ID-NET

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference64 articles.

1. Antibiotic resistance threats in the United States,2013

2. Genomic analysis of a pan-resistant isolate of Klebsiella pneumoniae, United States 2016;de Man;MBio,2018

3. Carbapenem resistance: a review;Codjoe;Med Sci (Basel),2017

4. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections;Falagas;Emerg Infect Dis,2014

5. Novel β-lactam/β-lactamase inhibitors versus alternative antibiotics for the treatment of complicated intra-abdominal infection and complicated urinary tract infection: a meta-analysis of randomized controlled trials;Chen;Expert Rev Anti Infect Ther,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides;World Journal of Microbiology and Biotechnology;2024-08-20

2. Ethics and global health security;Modernizing Global Health Security to Prevent, Detect, and Respond;2024

3. Inverse publication reporting bias favouring null, negative results;BMJ Evidence-Based Medicine;2023-06-14

4. All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies;Expert Review of Anti-infective Therapy;2022-01-12

5. NIMble innovation—a networked model for public antibiotic trials;The Lancet Microbe;2021-11